Sigma Planning Corp - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 124 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sigma Planning Corp ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$301,290
-30.7%
20,750
-0.0%
0.01%
-31.2%
Q2 2023$434,507
-11.5%
20,760
-10.7%
0.02%0.0%
Q1 2023$491,040
-25.6%
23,250
-10.4%
0.02%
-33.3%
Q4 2022$660,173
+7.2%
25,940
+1.2%
0.02%
+4.3%
Q3 2022$616,000
+34.2%
25,640
+7.6%
0.02%
+43.8%
Q2 2022$459,000
+7.5%
23,840
-3.1%
0.02%
+23.1%
Q1 2022$427,000
-20.6%
24,5900.0%0.01%
-13.3%
Q4 2021$538,000
+13.5%
24,590
-0.8%
0.02%
+7.1%
Q3 2021$474,000
+9.5%
24,790
-1.8%
0.01%
+7.7%
Q2 2021$433,000
-23.9%
25,240
-0.8%
0.01%
-27.8%
Q1 2021$569,000
+0.2%
25,440
-0.3%
0.02%
-5.3%
Q4 2020$568,000
+47.2%
25,525
-2.3%
0.02%
+26.7%
Q3 2020$386,0000.0%26,125
+0.4%
0.02%
-11.8%
Q2 2020$386,000
+238.6%
26,025
+111.9%
0.02%
+183.3%
Q2 2019$114,00012,2800.01%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,025,000$24,631,00016.36%
Kynam Capital Management, LP 2,272,915$54,618,00011.51%
Frazier Life Sciences Management, L.P. 3,412,838$82,010,0006.32%
Foresite Capital Management IV, LLC 690,000$16,581,0005.33%
Paradigm Biocapital Advisors LP 1,085,142$26,076,0003.48%
ACUTA CAPITAL PARTNERS, LLC 324,614$7,800,0003.36%
COMMODORE CAPITAL LP 738,110$17,737,0002.85%
SPHERA FUNDS MANAGEMENT LTD. 822,696$19,769,0002.74%
Avidity Partners Management LP 5,586,900$134,253,0002.73%
HealthCor Management, L.P. 859,240$20,648,0002.58%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders